Overview
Raised: $75,000
Rolling Commitments ($USD)
02/28/2024
$1,667
79
2019
Healthcare & Pharmaceuticals
Non-Tech
B2C
Low
High
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$1,206,050 |
$1,228,914 |
COGS |
$386,694 |
$391,752 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$65,754 |
$70,754 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$32,703 |
$54,295 |
Accounts Receivable |
$0 |
$-11 |
Total Assets |
$1,395,518 |
$332,319 |
Short-Term Debt |
$41,931 |
$17 |
Long-Term Debt |
$1,293,350 |
$288,478 |
Total Liabilities |
$1,335,281 |
$288,495 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual